Practice question
Mental illness: why is cardiometabolic risk monitoring important?
Antipsychotic medications used to treat people with mental illness can heighten the risk of cardiometabolic disease, here are tips for nurses on monitoring risk
Antipsychotic medications used to treat people with mental illness can heighten the risk of cardiometabolic disease, here are tips for nurses on monitoring risk
People with mental illness, especially those with severe mental illness (SMI) such as psychosis, have a life expectancy shortened by 20 years compared with the general population (Pradhan and Joshi 2018) . Leading causes of premature death are physical illness, especially cardiovascular disease (CVD), respiratory diseases and diabetes
Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Mental Health Practice
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests
Already registered or subscribed? Log in
This article is not available as part of an institutional subscription. Why is this?
